Natera – Healthcare Data News

Natera Announces Real-World Data Collaboration with Merck

November 14, 2023 08:00 AM Eastern Standard Time AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has entered into an agreement with...

January 11, 2023January 17, 2023 Collaborations Competitor News

Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with Natera

CAMBRIDGE, Mass. and AUSTIN, Texas, June 8, 2021 /PRNewswire/ — Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA), today announced the launch of the research use version of FoundationOne®Tracker, Foundation Medicine’s personalized circulating tumor DNA (ctDNA) monitoring assay. FoundationOne Tracker uniquely combines Foundation Medicine’s tissue-based comprehensive genomic profiling...